期刊文献+

CD147在膀胱尿路上皮癌组织中的表达及临床意义 被引量:1

Expression and clinical significance of extracellular matrix metalloproteinase inducer molecule CD147 in bladder urothelial carcinoma tissue
下载PDF
导出
摘要 目的探讨细胞外基质金属蛋白酶诱导因子CD147在膀胱尿路上皮癌组织中的表达及其与临床病理特征和预后的关系。方法应用RT-PCR和Western blot法检测CD147mRNA和蛋白在20例膀胱尿路上皮癌和对应的癌旁组织中的表达情况;应用组织芯片技术和免疫组织化学方法,检测CD147在108例膀胱尿路上皮癌和20例正常膀胱黏膜组织中的表达状况,分析CD147与膀胱尿路上皮癌患者的临床病理学特征及其与预后的关系。结果 CD147mRNA和蛋白在20例膀胱尿路上皮癌组织中的表达水平明显高于相应的癌旁组织,差异有统计学意义(P<0.01)。免疫组织化学检测发现,20例正常膀胱黏膜组织中CD147无表达或呈弱阳性表达,108例膀胱尿路上皮癌组织中CD147阳性表达率为73.1%。CD147表达与膀胱尿路上皮癌患者临床分期、病理分级、肿瘤大小和淋巴结转移密切相关(P<0.05),而与患者的年龄、性别以及肿瘤数目无关(P>0.05)。KaplanMeier生存曲线分析结果表明,高表达CD147的膀胱尿路上皮癌患者的总体生存时间明显短于CD147低表达患者,差异有统计学意义(P<0.01)。单因素分析结果表明,肿瘤临床分期、病理分级、淋巴结转移、肿瘤大小和CD147表达是影响膀胱尿路上皮癌患者预后的重要因素(P<0.05)。COX多因素生存分析结果表明,肿瘤临床分期、病理分级、淋巴结转移和CD147表达是影响膀胱尿路上皮癌患者预后的独立因素(P<0.05)。结论 CD147在膀胱尿路上皮癌中高表达,可能与膀胱尿路上皮癌的进展有关,其表达状态是膀胱尿路上皮癌患者预后的独立因素。 Objective To investigate the expression of extracellular matrix metalloproteinase inducer CD147 in patients with bladder urothelial carcinoma and its relationship with clinicopathologic features and prognosis.Methods RT-PCR and Western blot were used to evaluate the mRNA and protein expression of CD147 in cancer tissues and corresponding paracanerous tissues from 20 patients with bladder urothelial carcinoma;tissue microarray containing specimens from 108 patients with bladder urothelial carcino-ma and 20 normal controls was constructed and immunohistochemistry was applied to examine the expression of CD147,and the correlations between CD147 and clinicopathological characteristics and prognosis were also analyzed.Results Expression level of CD147 mRNA and protein in cancer tissues from 20 bladder urothelial carcinoma patients was significantly higher than that of cor-responding adjacent tissues(P〈0.01).Immunohistochemical detection showed normal bladder urothelium from 20 control cases were either no or weak protein expression of CD147,positive expression rate of CD147 in 108 cases of bladder urothelial carcinoma was 73.1%.the CD147 expression level had positive correlation with lymph nodes metastasis,histological grade,tumor stage and tumor size of patients with bladder urothelial carcinoma(P&lt;0.05)and had no relationship with age,sex,the number of tumor(P〉0.05).Kaplan-Meier survival curves analysis showed that the survival time of patients with bladder urothelial carcinoma whose ex-pression of CD147 were high was significant lower than that of patients with bladder urothelial carcinoma whose expression of CD147 were low(P〈0.01).Univariate analysis showed that histological grade,tumor stage,lymph node metastasis,tumor size and CD147 expression were all positively correlated with a poor prognosis(P〈0.05).Cox-multivariate analysis revealed that histologi-cal grade,tumor stage,lymph node metastasis,and CD147 expression level were independent predictors of an unfavorable prognosis (P〈0.05).Conclusion High expression of CD147 in bladder urothelial carcinoma may be correlate with the its progress and its expression state is an independent prognosis factor.
出处 《重庆医学》 CAS CSCD 北大核心 2014年第34期4574-4578,共5页 Chongqing medicine
关键词 膀胱肿瘤 CD147 组织芯片 urinary bladder neoplasms CD147 tissue microarray
  • 相关文献

参考文献3

二级参考文献21

  • 1Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量:214
  • 2马俭,乔宗海,吴四海.基质金属蛋白酶和细胞黏附因子CD147在喉鳞状细胞癌中的表达[J].中华耳鼻咽喉科杂志,2004,39(9):570-571. 被引量:4
  • 3Hai-GangLi,De-RongXie,Xi-MingShen,Hong-HaoLi,HongZeng,Yun-JieZeng.Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(10):1445-1451. 被引量:38
  • 4沃尔什.坎贝尔泌尿外科学:第 7版[M].北京:科学出版社,2001.2361- 2370.
  • 5Chambers AF, Marisian LM. Changing views of the role of matrix metalloproteinases in metastasis[J]. J Nat Cancer lnst, 1997,89:1260 - 1270.
  • 6Guo H, Li R, Zucker S, etal. EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface[J]. Cancer Res, 2000, 60:888 - 891.
  • 7Dalberg K, Eriksson E, Enberg U, et al. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: Correlation with invasive growth of breast cancer[J]. World J Surg, 2000.24:334 - 340.
  • 8Ozdemir E, Kakehi Y, Okuno H, et al. Role of matrix metalloproteinase-9 in the basement membrane destruction of superficial urothelial carcinomas[J]. J Urol, 1999, 161:1359 -1363.
  • 9Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumor invasion and metastasis[J]. Eur J Cancer, 2000, 36: 1621- 1630.
  • 10Brown PD, Bloxidge RE, Anderson E, et al. Expression of activated gelatinase in human invasive breast carcinoma[J]. Clin Exp Metastasis, 1993, 11(2): 183-189.

共引文献49

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部